199Immunoglobulin (Ig) therapy is the infusion of concentrated antibodies (i.e, immunoglobulins) into the vascular system. Immunoglobulins may be administered via the intravenous route (IVIg) or subcutaneously (SCIg). They are used…
171■ Were appropriate analgesics given according to the World Health Organization (WHO) cancer pain ladder for adults? These include appropriate use of oral opioid and nonsteroidal anti-inflammatory drugs (NSAIDs), and use…
99The infusion administration method is selected and based upon multiple factors including the type of infusion, the frequency of administration, infusion rate requirements, drug stability in solution, patient safety and…
155Administration of chemotherapy in the home setting varies across different regions of the country. Because of the need for close monitoring and risk of drug reactions, complex multidrug regimens are…
185Heart failure (HF) is a prevalent diagnosis among home care patients and is a costly condition associated with both high morbidity and mortality. As the U.S. population ages and as…
45Reliable vascular access is a major factor allowing for the success of home infusion therapy. Selecting the most appropriate vascular access device (VAD) as well as the site of placement…
123Antimicrobial drug administration is the most common home infusion therapy and is used to treat infections in both adult and pediatric patient populations. Given a safe home setting, an appropriate…
137Parenteral nutrition is the intravenous (IV) administration of nutrients via the venous system. In the past, IV nutrition was referred to as “hyperalimentation” or “total parenteral nutrition” but the current…
213The purpose of this chapter is to provide an overview of some less common, but often home-administered infusion therapies that do not fall under the broad headings of the previous…
15Effective teaching is unquestionably essential to the provision of safe home infusion therapy. Patient education is one of the four aspects of care that impact patient outcomes as described in…
